NASDAQ:CNXC 24 December 2025 - 14 January 2026

Concentrix shares rose 3.9% to $40.71 Wednesday after the company posted Q4 revenue of $2.55 billion and a $1.52 billion goodwill impairment charge. Adjusted profit and cash flow held steady, but BofA and Baird cut price targets, citing margin pressure. Concentrix forecast 2026 revenue of up to $10.18 billion and non-GAAP EPS as high as $12.07.

Concentrix (CNXC) traded nearly flat Friday morning, last quoted at $41.67, down 0.05% with early volume above 85,000 shares. The company will report Q4 and full-year 2025 results before market open on Jan. 13, 2026. Major U.S. equity ETFs were slightly higher, while small caps and bond ETFs showed mixed moves. Concentrix recently launched pre-built conversational AI agents targeting enterprise clients.